Huayu Pharmaceutical: The stock's consecutive two-day deviation from the increase reached 30%, warning of investment risks.

Huiyu Pharmaceuticals announced that the company's stock had abnormal trading fluctuations on April 1 and April 2, 2026, with a cumulative deviation of 30% in the closing price over the two consecutive trading days. After self-inspection and inquiries, the company, controlling shareholders, and actual controllers did not have any undisclosed significant issues, and the production and operation are currently normal. The company reminds that there is uncertainty in the research and development of innovative drugs, and the stock price may fluctuate greatly in the short term. Investors should make decisions with caution and be aware of the risks.